VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial

This publication has 30 references indexed in Scilit:

• Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease
  Gene Therapy, 2007
• Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment
  Gene Therapy, 2006
• An engineered VEGF‐activating zinc finger protein transcription factor improves blood flow and limb salvage in advanced‐age mice
  The FASEB Journal, 2006
• Longevity of the Placebo Effect in the Therapeutic Angiogenesis and Laser Myocardial Revascularization Trials in Patients With Coronary Heart Disease
  The American Journal of Cardiology, 2005
• The efficacy of a ‘master switch gene’ HIF-1α in a porcine model of chronic myocardial ischaemia
  European Heart Journal, 2005
• Direct intramyocardial plasmid vascular endothelial growth factor-A165gene therapy in patients with stable severe angina pectoris
  JACC, 2005
• Intracoronary administration of FGF-2: a computational model of myocardial deposition and retention
  American Journal of Physiology-Heart and Circulatory Physiology, 2005
• Nitric oxide and the angiogenic response: can we improve the results of therapeutic angiogenesis?
  Expert Opinion on Investigational Drugs, 2005
• Clinician Guide to Angiogenesis
  Circulation, 2003
• In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo
  Gene Therapy, 2001